Ritter Pharmaceuticals Companies
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
Total Funding:
25730038
Investor Type:
N/A
Technology:
Anti-infective Drugs
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
Less than $1M
Founded Date:
2004-01-01
Industry:
Healthcare InsurTech
Employee Number:
11-50
Last Funding Date:
2015
Funding Status:
IPO
Number Of Exists:
N/A
Headquarters:
Greater Los Angeles Area, West Coast, Western US